Insulet Corporation - Common Stock (PODD)
165.02
+10.16 (6.56%)
NASDAQ · Last Trade: Nov 4th, 7:37 PM EST
News & Press Releases
What Insulet (PODD) Said on Its Q3 Earnings Callmarketbeat.com
Insulet (NASDAQ:PODD) reported third-quarter revenue of $842 million, up 19.2% on a reported basis and 19.6% on a constant-currency basis, as international growth outpaced the company’s plans and U.S. performance landed within its guidance range.
President and Chief Executive Officer Ashley McEvoy
Via MarketBeat · November 4, 2026
Insulet (PODD) Q3 2026 Earnings Call Transcriptfool.com
Revenue beat guidance and the full-year outlook was narrowed upward.
Via The Motley Fool · November 4, 2026
Insulet (NASDAQ:PODD) posts better-than-expected sales in Q3 2026, stock soars
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up 19.2% year o...
Via StockStory · November 4, 2026
Insulet (NASDAQ:PODD): A Growth-at-a-Reasonable-Price Case With Strong Expansionchartmill.com
Via Chartmill · October 22, 2026
Insulet (NASDAQ:PODD) Offers Affordable Growth With Strong Fundamentalschartmill.com
Via Chartmill · September 30, 2026
Insulet Reports Third Quarter 2026 Results
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its financial results for the three months ended September 30, 2026.
By Insulet Corporation · Via Business Wire · November 4, 2026
Insulet to Participate in the 2026 Jefferies Global Healthcare Conference in London
Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the 2026 Jefferies Global Healthcare Conference in London on Wednesday, November 18, 2026, at 10:30 a.m. (GMT).
By Insulet Corporation · Via Business Wire · November 3, 2026
Insulet (PODD) Q3 earnings: what to expect
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting earnings this Wednesday morning. Here’s what to expect. Insulet beat analysts’ r...
Via StockStory · November 2, 2026
Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); and Planet Fitness, Inc. (NYSE: PLNT): Grabar Law Office is Investigating Claims on Your Behalf
PHILADELPHIA, Oct. 30, 2026 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · October 30, 2026
S&P 500 Postmarket Decliners After Tuesday's Closechartmill.com
Via Chartmill · October 27, 2026
2 Profitable Stocks to Keep an Eye On and 1 We Question
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via StockStory · October 19, 2026
2 of Wall Street’s Favorite Stocks to Target This Week and 1 We Ignore
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
Via StockStory · October 16, 2026
Insulet Announces Omnipod Discover Now Available in U.S.
Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the U.S. full market release of Omnipod Discover™, a web-based data platform designed for Omnipod 5 users, their caregivers, and healthcare providers (HCPs). Omnipod Discover turns critical diabetes data into clear visualizations and personalized insights, giving people with diabetes and their HCPs a shared understanding of therapy patterns to make more informed diabetes management decisions.
By Insulet Corporation · Via Business Wire · October 12, 2026
Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); Better Home & Finance Holding Company (NASDAQ: BETR); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Office is Investigating Claims on Your
PHILADELPHIA, Oct. 01, 2026 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · October 1, 2026
Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it will report financial results for the third quarter of 2026 on Wednesday, November 4, 2026, before the opening of the financial markets. In connection with the release, management will host a conference call that day at 8:00 a.m. (Eastern Time).
By Insulet Corporation · Via Business Wire · October 1, 2026
2 Safe-and-Steady Stocks to Consider Right Now and 1 Facing Challenges
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on hi...
Via StockStory · October 1, 2026
Insulet Targets Type 2 Retention as Omnipod 6 and Global Growth Gain Momentummarketbeat.com
Insulet (NASDAQ:PODD) Chief Operating Officer Eric Benjamin said the company remains focused on expanding adoption of automated insulin delivery, or AID, systems across large and underpenetrated diabetes markets, while addressing elevated early attrition among certain Type 2 diabetes customers.
Spe
Via MarketBeat · September 25, 2026
2 Healthcare Stocks with Impressive Fundamentals and 1 Facing Challenges
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali...
Via StockStory · September 25, 2026
Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum
Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum on Thursday, September 24, 2026, at 12:30 p.m. (Eastern Time).
By Insulet Corporation · Via Business Wire · September 18, 2026
Important Notice to Long-Term Shareholders of FuelCell Energy, Inc. (NASDAQ: FCEL); Insulet Corporation (NASDAQ: PODD); Papa John's International, Inc. (NASDAQ: PZZA); and York Space Systems Inc. (NYSE: YSS): Grabar Law Office is Investigating Claims on
PHILADELPHIA, Sept. 14, 2026 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · September 14, 2026
2 S&P 500 Stocks with Impressive Fundamentals and 1 We Turn Down
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...
Via StockStory · September 14, 2026
Unpacking Q2 Earnings: Insulet (NASDAQ:PODD) In The Context Of Other Patient Monitoring Stocks
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) ...
Via StockStory · September 2, 2026
Important Notice to Long-Term Shareholders of Hub Group, Inc. (NASDAQ: HUBG); Hyliion Holdings Corp. (NYSE: HYLN); Insulet Corporation (NASDAQ: PODD); and York Space Systems Inc. (NYSE: YSS): Grabar Law Office is Investigating Claims on Your Behalf
PHILADELPHIA, Sept. 02, 2026 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · September 2, 2026
Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); Hub Group, Inc. (NASDAQ: HUBG); and Insulet Corporation (NASDAQ: PODD): Grabar Law Office is Investigating Claims on Your Behalf
PHILADELPHIA, Sept. 01, 2026 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · September 1, 2026
PODD DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) and reminds investors of the August 31, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
By Faruqi & Faruqi, LLP · Via Business Wire · August 31, 2026